MEGAPEN - STREP INJECTION
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
30-04-2024
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
PROCAINE BENZYL PENICILLIN (LECITHIN COATED), DIHYDROSTREPTOMYCIN SULFATE
Inapatikana kutoka:
Franklin Pharmaceuticals Ltd.
ATC kanuni:
QJ01RA
INN (Jina la Kimataifa):
PROCAINE BENZYL PENICILLIN (LECITHIN COATED), DIHYDROSTREPTOMYCIN SULFATE
Kipimo:
20/20
Dawa fomu:
Suspension for Injection
Dawa ya aina:
POM
Kundi la matibabu:
Bovine
Eneo la matibabu:
Combinations of antibacterials
Matibabu dalili:
Antibacterial
Idhini hali ya:
Authorised
Idhini ya tarehe:
1987-10-01
Tabia za bidhaa
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Megapen - Strep Injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Suspension for injection.
A white aqueous solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Bovine.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and control of infections caused by bacteria sensitive to procaine penicillin or dihydrostreptomycin
sulphate.
4.3 CONTRAINDICATIONS
Do not use in cases of known hypersensitivity to the active ingredients.
Do not administer by the intravenous route.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
Each ml contains:
Active substances
Procaine Benzylpenicillin
200 mg
Dihydrostreptomycin Sulphate
200 mg
Excipient
Methyl Parahydroxybenzoate
1.0 mg
Sodium Formaldehyde Sulfoxylate
1.48 mg
For a full list of excipients, see section 6.1
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 28/04/2011_
_CRN 7010620_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not
possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the
target bacteria.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Avoid direct contact with product. Use gloves when administering the product. Seek medicinal advice if symptoms
such as skin rash, swelling of face, lips etc occurs.
Penicillin and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin
contact. Hypersensitivity to penicillin may lead t
Soma hati kamili
